fda compounding semaglutide enforcement november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Drugmakers battle pharmacies over compounded

Leah Joseph, MD, FACP , provides expert guidance to help you choose the best treatment for your needs

As part of this shift, we formed a collaboration with Novo Nordisk to help customers access Wegovy injections and pills

For individuals currently seeking weight management support in the UK, options recommended by NICE include: Orlistat available on NHS prescription and over the counter

GLP induced weight & muscle loss has lowered your metabolic rate

But the gap is large enough that it is hard to explain away with population differences alone

These include feeling nauseated, vomiting, diarrhea, upset stomach, headache, dizziness and a complete loss of appetite